Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free ENTA Stock Alerts $17.46 +0.93 (+5.63%) (As of 03/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.64%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$257,949.03 Get ENTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENTA Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Enanta Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2023Terry VanceDirectorSell15,295$9.12$139,490.40 12/5/2023Brendan LuuVPSell2,125$9.63$20,463.75 12/5/2023Jay R LulyCEOSell7,230$9.63$69,624.90 12/5/2023Paul J MellettCFOSell2,412$9.63$23,227.56 12/5/2023Scott T RottinghausCMOSell534$9.63$5,142.42 (Data available from 1/1/2013 forward) ENTA Insider Trading Activity - Frequently Asked Questions Who is on Enanta Pharmaceuticals's Insider Roster? The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Bruce L A Carter, Jay R Luly, Nathalie Adda, Paul J Mellett, Scott T Rottinghaus, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA. What percentage of Enanta Pharmaceuticals stock is owned by insiders? 13.64% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings. Which Enanta Pharmaceuticals insiders have been selling company stock? The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($2,671,730.82), Nathalie Adda ($5,967,738.87), Paul J Mellett ($755,876.76), Scott T Rottinghaus ($5,142.42), Terry Vance ($139,490.40), and Yat Sun Or ($618,966.25). How much insider selling is happening at Enanta Pharmaceuticals? Insiders have sold a total of 198,217 Enanta Pharmaceuticals shares in the last 24 months for a total of $10,179,409.27 sold. Which members of congress are trading Enanta Pharmaceuticals? Daniel S. Goldman (D-NY) has sold shares of Enanta Pharmaceuticals in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: RAPT Insider Trading XOMA Insider Trading XERS Insider Trading SBTX Insider Trading ERAS Insider Trading GOSS Insider Trading ATAI Insider Trading ANNX Insider Trading PRLD Insider Trading AVIR Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:ENTA) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.